Dan Weng
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Dan Weng is currently President & Chief Executive Officer at Medelis, Inc. since 2018.
Dr. Weng is President & Representative Director at EPS International Co. Ltd. since 2013.
Dr. Weng is President & Representative Director at EPS Global Research, Inc. since 2012.
Dr. Weng is Representative Director at EPS International Korea Ltd. since 2012.
Dr. Weng is Representative Director at Ever Progressing System (Hong Kong) Ltd. since 2012.
Dr. Weng is Independent Director at Gyre Therapeutics, Inc. starting 2025.
Former roles include Chief Executive Officer & Director at Ergomed Group Ltd. in 2017, Director & Senior Executive Officer at EPS Holdings, Inc. from 2013 to 2016, and Vice President at Medpace, Inc. Education includes graduate degree from the University of Leeds and doctorate from Tongji Medical College of Huazhong University of Science & Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 10.06.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Präsident | 01.12.2013 |
EPS International (Korea) Ltd.
EPS International (Korea) Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on medical sciences | Direktor/Vorstandsmitglied | 01.06.2012 |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical trials | Präsident | 01.06.2014 |
Ever Progressing System (Hong Kong) Ltd.
Ever Progressing System (Hong Kong) Ltd. MiscellaneousMiscellaneous Operates as an non-classified establishment | Direktor/Vorstandsmitglied | 01.03.2012 |
Medelis, Inc.
Medelis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as oncology clinical research organization | Vorstandsvorsitzender | 01.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| ERGOMED | Vorstandsvorsitzender | 15.12.2017 |
| EPS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 22.12.2016 |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to the pharmaceutical, biotech and medical industries | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Medelis, Inc.
Medelis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as oncology clinical research organization | Commercial Services |
EPS Holdings, Inc.
EPS Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in clinical research, drug development, testing, post-marketing, medical systems, related research and incubation services | Commercial Services |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to the pharmaceutical, biotech and medical industries | Commercial Services |
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Tongji Medical College of Huazhong University of Sci & Tech
Tongji Medical College of Huazhong University of Sci & Tech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical trials | Commercial Services |
Ergomed Plc
Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
EPS International (Korea) Ltd.
EPS International (Korea) Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on medical sciences | Commercial Services |
Ever Progressing System (Hong Kong) Ltd.
Ever Progressing System (Hong Kong) Ltd. MiscellaneousMiscellaneous Operates as an non-classified establishment | Miscellaneous |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen